This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Management of proliferative diabetic retinopathy

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Principal goal is prevention with

  • systemic and local measures (1)
    • good glycaemic control
    • control of hypertension

Treatment is directed at regressing neovascularisation using Argon laser pan-retinal photocoagulation

  • the new vessels themselves are not targeted but photocoagulation is spread over a wide area in order to destroy ischaemic retina and remove the vasoproliferative stimulus
  • there is variable visual loss and night blindness.

Vitrectomy is indicated if a vitreous haemorrhage has not resolved spontaneously within 6 months or retinal detachment is suspected.

  • vitrectomy (2)
    • a surgical technique
      • approached from the pars plana,
      • vitreous excised
      • suctioning the gel done
      • replaced with aqueous fluid.
      • fibrous tissue removed
      • areas of retinal detachment flattened

Patients with neovascular glaucoma or high-risk proliferative diabetic retinopathy should receive prompt scatter photocoagulation (3)

Gene therapy for ocular neovascularization is still under study (4)

Future treatment prospects under trial include (5)

  • protein kinase C inhibitors,
  • intravitreal steroid,
  • anti-vascular endothelial growth factor agents,
  • angiotensin converting enzyme inhibitors,
  • growth hormone

Pan-retinal photocoagulation may prevent thrombotic glaucoma but once developed, this may be difficult to treat.

Untreated eyes with severe disease have about 40% risk of severe visual loss within two years.

Reference:

  1. American Academy of Ophthalmology, basic and clinical science course,2005-2006, retina and vitreous, section12, 99-119
  2. Ferris FL et al. Treatment of Diabetic Retinopathy.N Engl J Med 1999;341:667.
  3. Campochiaro PA.Gene therapy for ocular neovascularization. Curr Gene Ther. 2007 Feb;7(1):25-33.
  4. American Academy of Ophthalmology Retina Panel (2003). Diabetic Retinopathy,Preferred Practice Pattern® Guideline
  5. Yam JC et al. Update on the treatment of diabetic retinopathy.Hong Kong Med J. 2007 Feb;13(1):46-60.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.